Award
Delivery Order #SPE2DR26F2B63
Short-Term Delivery Order for Ondansetron from AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$20.14
Ceiling
$20.14
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26F2B63
NAICS
424210
This award represents a delivery order contract under a previously established indefinite delivery vehicle with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor. The contract covers the supply of Ondansetron HCL 4 mg/2 ml vials, a medication commonly used to prevent nausea and vomiting, indicating its role in supporting healthcare services. The order is significant for ensuring timely availability of essential pharmaceuticals, contributing to sustained public health delivery. The scope involves delivering the specified pharmaceutical product within a brief, defined timeframe, reflecting a focused procurement action. This contract builds upon AmerisourceBergen’s ongoing pharmaceutical supply agreement with the agency, which was awarded competitively to maintain a reliable supply chain through a long-term framework. The delivery order's short performance period highlights its use for immediate or specific operational needs.
Description
4570819932!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML